St. Paul Business Journal recently hosted a roundtable discussion about how to best navigate and make the most of a mergers ...

The 81-foot lighthouse has been hidden behind barbed wire for decades, but a multi-organization effort is working to bring it ...

Heavy smoke pouring out of the eaves of the South Main Auto Body Shop on South Main Street caught the attention of a ...

The prior listing of American Depositary Shares and the various US dollar bonds issued by the Company and AstraZeneca Finance LLC (AstraZeneca US Bonds) on Nasdaq in the US ceased on 30 January 2026.

Dr. James McCaffrey presents a complete end-to-end demonstration of linear regression with pseudo-inverse training implemented using JavaScript. Compared to other training techniques, such as ...

A step-by-step guide to installing the tools, creating an application, and getting up to speed with Angular components, ...

Abstract: As an essential part of the website, JavaScript greatly enriches its functions. At the same time, JavaScript has become the most common attack payload on malicious websites. Although ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure, which concentrates on metabolic diseases with a particular focus on obesity, unveiled the topline data for its GLP-1 drug aleniglipron. The weight-loss treatment was put through its paces ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...